Protalix Biotherapeutics Inc (NYSE American:PLX)

3.79
Delayed Data
As of 4:10pm ET
 -0.13 / -3.32%
Today’s Change
1.70
Today|||52-Week Range
6.00
+15.55%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Protalix Biotherapeutics Inc have a median target of 20.50, with a high estimate of 30.00 and a low estimate of 11.00. The median estimate represents a +440.90% increase from the last price of 3.79.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Protalix Biotherapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.27
Sales
$12.9M
Reporting Date
Mar 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -32.50%
 
 
 
 
 
 
Growthannually 20.00%
 
 
 
 
 
 

Sales

Growthquarterly -9.81%
 
 
 
 
 
 
Growthannually 456.30%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.